SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending downwards as investors react to increased spending forecasts related to AI, drawing comparisons to the company's metaverse investments; the community is debating whether this dip represents a buying opportunity or signals deeper concerns about Meta's direction, with some citing a one-time tax charge as the primary driver, while others point to overall market weakness or algorithmic reactions.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the iconic Rage Guy meme, emphasizing a return to OG meme culture and community-driven growth. Discussions highlight the importance of belief and shared effort, with community members expressing bullish sentiment and encouraging each other to "RAGE ON" and "work for their bags". The movement is positioned as a cultural correction against soulless memecoins.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors anticipate the company's earnings report and how effectively it's monetizing data through AI partnerships. Community members are discussing revenue estimates, daily active user growth, and the potential for a post-earnings rally or selloff. Some are also pointing to potential connections with other trending stocks and broader market factors.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific ($CORZ) is trending as shareholders prepare to vote on a proposed merger with CoreWeave ($CRWV), with many in the community expressing concerns that the deal undervalues $CORZ, particularly given its AI infrastructure potential. Some investors believe that rejecting the deal could lead to a higher valuation for $CORZ as a standalone entity or attract a better offer, while others worry about the company's future prospects without the merger.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle ($CMG) is trending due to a significant drop following a lowered sales outlook, sparking discussions about consumer spending and the company's value proposition. Community members are debating whether the dip is a buying opportunity or a sign of deeper issues with the brand, citing concerns about pricing, portion sizes, and competition in the fast-casual dining sector.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

EBS is trending due to raised FY25 EBITDA guidance, sparking optimism about the company's future profitability. The community is discussing the potential for a significant stock re-rating and a short squeeze, with some highlighting the low P/E ratio relative to the broader market. Discussions also involve potential catalysts like government appropriations and debt refinancing.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid unconfirmed rumors of a potential buyout, sparking active discussions within the investment community. The speculation surfaces as the company focuses on oncology and prepares to report earnings in November. Community members are weighing the potential deal price and strategic implications for Moderna's future.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC is trending as investors digest recent earnings and a reduced dividend, leading to a sharp price decline. The community is debating whether this presents a value opportunity or signals deeper challenges for the company, with some citing an overreaction and oversold conditions. Bullish sentiment is building around potential for a price rebound given its inclusion in the S&P 500.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as community members discuss the potential for a short squeeze, driven by high short interest and optimism around the company's pipeline. Chatter revolves around buyout speculation, comparisons to competitors, and anticipation for upcoming presentations at ObesityWeek. The stock's recent performance and market dynamics in the obesity treatment sector are also fueling the conversation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is trending due to upcoming Phase 3 data for its DMD treatment, with investors closely watching for positive results that could lead to FDA approval; community chatter reflects both excitement and apprehension, as the data represents a pivotal moment for the company. Community members also highlight BlackRock's substantial stake in Capricor. Some traders cite the potential for a significant short squeeze based on the stock's high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ASP Isotopes Inc. (ASPI) announced on Wednesday the pricing of its underwritten public offering of more than 17 million shares of common stock, with total gross proceeds amounting to approximately $210.3 million.The advanced materials company, which focuses on isotope production technology for various industries, expects the transaction to close on October 16, pending&nbsp;customary closing conditions.The company stated that underwriters will have a 30-day option to buy extra shares valued at around $31.5 million.&nbsp;<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes’ stock</a> traded over 8% lower in Wednesday’s premarket and was among the top five equity tickers on Stocktwits. Retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;ASP Isotopes plans to allocate the net proceeds to strengthen its working capital and support ongoing operational costs.&nbsp;On Monday, the company revealed that it had signed a supply agreement in September with a U.S. customer for isotopically pure silicon-28, with shipments scheduled for the first quarter of 2026.Enriched silicon-28 is a critical element for quantum computing and next-generation chip technologies. By eliminating nuclear spin interference found in natural silicon, silicon-28 enables better qubit performance, which is essential for creating stable and scalable quantum processors.The company uses its proprietary Aerodynamic Separation Process (ASP) technology to produce and commercialize enriched isotopes for healthcare and technology markets. It is also developing Quantum Enrichment technology to support isotope production for the nuclear energy sector.ASP Isotopes’ stock has gained over 210% in 2025 and over 384% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/reddit-stock-rises-premarket-goldman-sachs-sees-ads-data-licensing-boost/ch6nYAxR3Nb">Reddit Stock Rises Premarket: Goldman Sachs Sees Boost From Digital Ads, Data Licensing</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ASP Isotopes logo is seen displayed on a smartphone screen.

ASP Isotopes Stock Plummets Pre-Market After Announcing Pricing Of Public Offering

The company expects the transaction to close on October 16, pending routine conditions.

Equity

The company expects the transaction to close on October 16, pending routine conditions.


ASP Isotopes (ASPI) stock fell 8.8% in extended trading on Tuesday after the company unveiled a proposed offering of its common stock.The move comes after the stock closed at an all-time high on Tuesday. The company said Cantor Fitzgerald and Lucid Capital Markets are the joint book runners of the offering. It did not, however, disclose how much it was looking to raise.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes</a> was in the ‘extremely bullish’ territory at the time of writing.<figure class="image"><img style="aspect-ratio:796/92;" src="https://news.stocktwits-cdn.com/ASPI_oct_14_JPG_19d8ad95b9.webp" alt=" ASPI’s Sentiment Meter and Message Volume as of 10:31 p.m. ET on Oct. 14, 2025 | Source: Stocktwits" width="796" height="92"><figcaption>ASPI’s Sentiment Meter and Message Volume as of 10:31 p.m. ET on Oct. 14, 2025 | Source: Stocktwits</figcaption></figure>The company had about 91.91 million shares outstanding as of Aug. 14, along with a market capitalization of about $1.29 billion. Separately, the company revealed that it has filed for a mixed shelf offering of up to $250 million. Businesses use this method to pre-register equities, keeping them on the "shelf," and then quickly sell them when market conditions are favorable.Many retail traders dismissed dilution concerns by citing examples of other stocks that quickly rebounded after a dip in valuation following a stock offering. “This sector is so hot and huge [in] growth that nothing can stop this train,” one Stocktwits user said.<stembedurl>https://stocktwits.com/BioResearcher/message/632346282</stembedurl>Earlier this week, the company shared a couple of recent business updates which has propelled the stock to record highs. The company revealed that it had signed a supply agreement in September with a U.S. customer for isotopically pure silicon-28, with shipments scheduled for the first quarter of 2026.Enriched silicon-28 is a critical element for quantum computing and next-generation chip technologies. By eliminating nuclear spin interference found in natural silicon, silicon-28 enables better qubit performance, which is essential for creating stable and scalable quantum processors.Separately, it said that in October, ASP Isotopes acquired a Florida-based radiopharmacy, representing its PET Labs unit’s first operational footprint beyond South Africa. ASP Isotopes stock has nearly tripled this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-sable-offshore-stock-plunge-nearly-27-after-hours-today/ch6nivvR3ZO">Why Did Sable Offshore Stock Plunge Nearly 27% After-Hours Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did ASP Isotopes Stock Tumble Over 8% After-Hours Today?

Earlier this week, the company shared a couple of recent business updates which has propelled the stock to record highs.

DOE Meets With Nuclear Companies Today To Kick Off Defense Production Act Consortium

DOE Meets With Nuclear Companies Today To Kick Off Defense Production Act Consortium Today is October 14, and as the Office of Nuclear Energy wrote back in August, should mark the first meeting of...

The Next Nuclear Story Stock: ASP Isotopes Shares Surge After Supply Contract For Silicon-28 And U.S. Radiopharmacy Acquisition

The Next Nuclear Story Stock: ASP Isotopes Shares Surge After Supply Contract For Silicon-28 And U.S. Radiopharmacy Acquisition ASP Isotopes, a name we pointed out to our subscribers about one week...

ASP Isotopes Inc. (ASPI) announced on Monday that it has locked in its largest enriched silicon-28 supply deal to date and acquired a U.S.-based radiopharmacy to support the expansion of its South African subsidiary, PET Labs.The company signed a supply agreement in September with a U.S. customer for isotopically pure silicon-28, with shipments scheduled for the first quarter of 2026. In October, ASP Isotopes acquired a Florida-based radiopharmacy, representing PET Labs' first operational footprint beyond South Africa.&nbsp;The acquisition is expected to be accretive to 2026 revenues, earnings before interest, taxes, depreciation, and amortization (EBITDA), and earnings per share (EPS).Following the business updates,&nbsp;<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes’ stock</a> traded over 17% higher on Monday morning, after the opening bell, and was among the top-five trending equity tickers on Stocktwits. Retail sentiment around the stock remained in ‘bullish’ territory amid ‘high’ message volume levels.&nbsp;Enriched silicon-28 is a critical element for quantum computing and next-generation chip technologies. By eliminating nuclear spin interference found in natural silicon, silicon-28 enables better qubit performance, which is essential for creating stable and scalable quantum processors.&nbsp;“Enriched silicon is emerging as a cornerstone material not only for quantum computing but also for high-precision semiconductor and photonics applications. Our goal is to become the world’s most reliable supplier of enriched silane and other isotopically pure gases — a foundation for the technologies driving the next industrial revolution,” said Chief Commercial Officer, Viktor Petkov.&nbsp;The acquired radiopharmacy facility currently provides SPECT imaging services, but PET Labs aims to introduce PET imaging capabilities by 2027.&nbsp;ASP Isotopes’ stock has gained over 123% in 2025 and over 234% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/klarna-joins-google-open-payments-protocol-ap2/ch6S1P4R3kk">Klarna Joins Google’s Open Payments Protocol AP2</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ASP Isotopes Stock Surges 17% After Silicon-28 Deal, Radiopharmacy Acquisition

The silicon-28 shipments are scheduled for the first quarter of 2026, and the radiopharmacy deal is expected to be accretive to 2026 revenues, EBITDA, and EPS.

ASP Isotopes Stock Surges 11% After Silicon-28 Deal, Radiopharmacy Acquisition

The silicon-28 shipments are scheduled for the first quarter of 2026, and the radiopharmacy deal is expected to be accretive to 2026 revenues, EBITDA, and EPS.



Shares of ASP Isotopes (ASPI) closed 6.1% higher at $9.36 on Friday.Last week, the company struck a four-year supply agreement with Isotopia Molecular Imaging to deliver enriched Gadolinium-160 (Gd-160), a key ingredient in producing Terbium-161 (Tb-161), a promising isotope for targeted radiotherapeutics.ASP will supply the isotope using its proprietary Quantum Enrichment technology from 2026, and&nbsp;the deal is expected to generate at least $1 million per year.The agreement is designed to help overcome persistent supply shortages of Gd-160, enabling Isotopia to advance its Tb-161-based treatments for cancers like prostate and neuroendocrine tumors.“By supplying Gd-160, we are eliminating a major bottleneck in the development of Tb-161 therapies. Our investment in enrichment technology positions us to support the radiopharmaceutical industry’s growing demand for stable isotopes,” said Paul Mann, CEO of ASP Isotopes.“This partnership accelerates the path to clinical adoption of Tb-161, which could redefine cancer treatment paradigms.”Last month, ASP signed a deal to supply enriched uranium to TerraPower, the nuclear energy company backed by Bill Gates.&nbsp;As part of the agreement, TerraPower will provide ASP with a multiple-advance term loan to help fund a planned uranium enrichment facility at Pelindaba, South Africa.Retail sentiment on Stocktwits remained ‘bullish’ ahead of Monday’s trading session.<figure class="image"><img style="aspect-ratio:969/96;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_09_122253_png_3a77496e48.webp" alt="Screenshot 2025-06-09 122253.png" width="969" height="96"><figcaption>ASPI's Sentiment Meter and Message Volume as of 3:17 a.m ET on June 9, 2025 | Source: Stocktwits&nbsp;</figcaption></figure>One user believes the stock should reach at least $20 before considering selling.<stembedurl>https://stocktwits.com/trent1229/message/617231598</stembedurl><a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes stock</a> has gained over 100% year-to-date.

DocuSign expects the new agreement to expedite the advancement of its IAM platform and deliver more intelligent and efficient solutions to its customers. 

ASP Isotopes Stock Jumps On Isotopia And TerraPower Tie-Ups: Retail Stays Bullish

The Isotopia agreement aims to deliver enriched Gadolinium-160 (Gd-160) to aid targeted radiotherapeutics

ASP Isotopes (ASPI) stock jumped in extended trading on Monday after the company signed an agreement to supply enriched uranium to Bill Gates-backed nuclear energy firm TerraPower.Under the agreement terms, Terrpower would provide ASP with a multiple-advance term loan to partially finance a proposed new uranium enrichment facility at Pelindaba, South Africa.The facility would be capable of producing high-assay low-enriched uranium (HALEU) with an annual output of approximately 15 metric tons.The company also agreed to supply HALEU for the first fuel core for TerraPower’s Natrium Plant in Wyoming. ASP expects to provide 150 metric tons of HALEU from 2028 through the end of 2037.The South Africa facility is expected to begin operations in 2027 upon receipt of all required permits and licenses.Monday’s agreement finalized a term sheet agreement between the two companies, which was struck last year.“Nuclear fuel has one of the most severely compromised supply chains of any material in the world. The world is in urgent need of additional suppliers,” ASP CEO Paul Mann said.HALEU is enriched between 5% and 20% and is the key to many advanced, smaller reactors with more power per unit of volume.There is a broad bipartisan support for nuclear power, which the U.S. lawmakers believe could be the answer to the rapid rise in power demand. However, currently, Russia is the only viable HALEU supplier of scale.The companies said they would explore opportunities to produce HALEU within the U.S.Retail sentiment on Stocktwits was in the ‘extremely bullish’ (81/100) territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:878/102;" src="https://news.stocktwits-cdn.com/ASPI_May_20_JPG_2e0ea8a23b.webp" alt="ASPI’s Sentiment Meter and Message Volume as of 02:47 a.m. ET on May 20, 2025 | Source: Stocktwits" width="878" height="102"><figcaption>ASPI’s Sentiment Meter and Message Volume as of 02:47 a.m. ET on May 20, 2025 | Source: Stocktwits</figcaption></figure>“This feels like where we were before Fuzzy Panda. This time, though, even though its prospects and potential are the same as then, the company is in a stronger position,” one retail trader said.<stembedurl>https://stocktwits.com/wilmeriken/message/615185094</stembedurl>The stock declined in November after short seller Fuzzy Panda <a href="https://stocktwits.com/news-articles/markets/equity/aspi-stock-slides-after-fuzzy-panda-short-call/cJIWDFNRWc">accused the company</a> of misleading investors. ASP had denied the allegations.<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes stock</a> has gained 60% year to date (YTD).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/citi-downgrades-patterson-uti-helmerich-and-payne-on-oil-price-risk/ch0dF7jRb8M">Citi Downgrades Patterson-UTI, Helmerich &amp; Payne On Oil Price Risk — Retail Surprised By ‘Brutal’ Selloff</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ASP Isotopes Rises On Deal With Bill Gates-Backed TerraPower — Retail Says Company Can Finally Move Beyond Short-Seller Report

Under the agreement terms, Terrpower would provide ASP with a multiple-advance term loan to partially finance a proposed new uranium enrichment in South Africa.

ASP Isotopes Rises On Deal With Bill Gates-Backed TerraPower

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ASP Isotopes Inc. (NASDAQ: ASPI)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ASP Isotopes Inc. (NASDAQ: ASPI) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...

4 Top-Rated Nuclear Energy Stocks to Buy in February 2025

These nuclear energy stocks all are loved by analysts and have significant upside potential over the next 12 months.

ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit with the Schall Law Firm

ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit with the Schall Law Firm ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit with the...

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

ASPI
ASP Isotopes Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ASPI News

ASPIASP Isotopes Inc